Cannvas Extends Trip to Asia Due to Significant Interest in Patient-Centric Life Sciences Learning Platform
TORONTO, July 6, 2018 /CNW/ – Cannvas MedTech Inc. (“Cannvas” or the “Company”) (CSE: MTEC), a leading business technology company within the cannabis health sciences space, is pleased to announce that its leadership team has extended its trip to Asia to meet with additional leading technology and cannabis related organizations in Asia. Shawn Moniz, Chief Executive Officer, and Steve Loutskou, Chief Operating Officer, Global Markets, of Cannvas are in Tokyo, Japan followed by Hong Kong, China, to attend RISE 2018, the largest tech conference in Asia which brings together some of the most brilliant minds in international tech in one place.
“We are extending our stay in Asia as there is considerable interest in our scalable Cannvas platform due to international recognition of the benefits of medical cannabis,” said Steve Loutskou, Chief Operating Officer, Global Markets, Cannvas MedTech Inc. “Over the past several months we have been aggressively vetting various markets around the world and have developed a global expansion strategy. Our discussions with cultivators, policy makers, government representatives, physician and medical groups around the world, all convey the same message, the need for education. Cannvas is well positioned for aggressive global expansion, as we roll out the first phase of our education platform.”
Cannvas is launching a patient-centric life science learning platform which has gained worldwide attention as more and more countries take the steps to legalize medical cannabis and explore the need for education on a broad scale. Through partnerships and joint ventures with other leading international businesses, research and scientific organizations, and government bodies, Cannvas.me offers patients a more powerful, single source of organized, trusted and accessible data, information and knowledge about cannabis.
With an impressive lineup of speakers and exhibitors RISE 2018 offers potential opportunities in health sciences and technology on an international stage. From Fortune 500 companies to groundbreaking startups, RISE will be host to over 15,000 attendees and over 350 speakers from over 90 countries representing today’s leaders in technology. RISE is taking place at the Hong Kong Conference and Exhibition Centre in Hong Kong, China from July 9 – 12, 2018, and consists of 13 conferences connecting every industry. For additional information on RISE 2018 visit www.riseconf.com.
About Cannvas MedTech Inc.
Cannvas MedTech is a leading business technology company within the cannabis space. We design and build customer-centric solutions that enable our partners to harness the power of data to truly understand their customers, industry, and key business drivers.
No stock exchange or securities regulatory authority has reviewed or accepted responsibility for the adequacy or accuracy of this release.
Some of the statements contained in this release are forward-looking statements, such as estimates and statements that describe the Issuer’s future plans, objectives or goals, including words to the effect that the Issuer or management expects a stated condition or result to occur. Since forward-looking statements address future events and conditions, by their very nature, they involve inherent risks and uncertainties. For a description of the risks and uncertainties facing the Company and its business and affairs, readers should refer to the Company’s Management’s Discussion and Analysis and other disclosure filings with Canadian securities regulators, which are posted onwww.sedar.com.
SOURCE Cannvas MedTech Inc.
For further information: www.cannvasmedtech.com, Media Inquiries, email@example.com; Investor Relations, firstname.lastname@example.org, 1-800-489-0116